Literature DB >> 22898233

Severe pancytopenia following etanercept administration in rheumatoid arthritis.

Virginia Martínez Santana, María Izquierdo Navarro, Miguel Ángel Calleja Hernández, Teresa Sánchez Sánchez, María Sainz Gil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22898233     DOI： 10.1111/j.1756-185X.2012.01740.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  5 in total

Review 1.  Adverse reactions to biologic agents and their medical management.

Authors:  Onur Boyman; Denis Comte; François Spertini
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

Review 2.  Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence.

Authors:  Sambhawana Bhandari; Maun Ranjan Baral; Matthew Barbery; Alla Rudinskaya; Oleg Sostin
Journal:  Ann Hematol       Date:  2022-06-27       Impact factor: 4.030

3.  Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis.

Authors:  Virginia Martínez-Santana; E González-Sarmiento; Ma Calleja-Hernández; T Sánchez-Sánchez
Journal:  Patient Prefer Adherence       Date:  2013-07-29       Impact factor: 2.711

4.  Peripheral Etanercept Administration Normalizes Behavior, Hippocampal Neurogenesis, and Hippocampal Reelin and GABAA Receptor Expression in a Preclinical Model of Depression.

Authors:  Kyle J Brymer; Erin Y Fenton; Lisa E Kalynchuk; Hector J Caruncho
Journal:  Front Pharmacol       Date:  2018-02-20       Impact factor: 5.810

5.  The relationship between blood eosinophil count and disease activity in ankylosing spondylitis patients treated with TNF-α inhibitors.

Authors:  Gokhan Sargin; Taskin Senturk; Irfan Yavasoglu
Journal:  Saudi Pharm J       Date:  2018-05-04       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.